Iridex to Participate in Fireside Chat with Stifel Equity Research
December 06, 2022 17:07 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Record Third Quarter 2022 Financial Results
November 10, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022
October 27, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022
September 29, 2022 16:05 ET
|
IRIDEX Corporation
MicroPulse® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways...
Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 18, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Second Quarter 2022 Financial Results
August 15, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended July 2, 2022. Second Quarter 2022 Highlights...
Iridex to Report Second Quarter 2022 Financial Results on August 15, 2022
August 01, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China
June 14, 2022 09:21 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces First Quarter 2022 Financial Results
May 12, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 2, 2022. First Quarter 2022 Highlights...
Iridex to Report First Quarter 2022 Financial Results on May 12, 2022
April 28, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...